The National Academy for State Health Policy (NASHP) interviewed state Medicaid, behavioral health, and public health officials from Colorado, Pennsylvania, and Texas to learn about their unique interagency approaches to treating and supporting pregnant and parenting women with substance use disorder (SUD).
This brief summarizes the accomplishments, key findings, and conclusions that emerged from three In-Depth Technical Assistance (IDTA) Infants with Prenatal Substance Exposure (IPSE) sites.
Steps you can take to decrease the impact of parental or household substance use
Information sheet from MACS Consultant, Marc Fishman, MD
Maryland Substance Exposed Newborn Tool Kit
The purpose of the toolkit is to educate the public, including, community service providers, local agencies, and health professionals, as to best practices for supporting substance exposed newborns and families impacted by substance use.
The Role of Primary Care Providers in Decreasing Impact of Parental Addiction (National Association for Children of Addiction)
Family practitioners and others can act as important advocates for appropriate community and school-based prevention approaches and in educating patients and parent, ensuring that local programs are culturally relevant and appropriate for the various communities and populations they serve.
Parental Addiction Resources for Providers (Sesame Street)
Resources to help children and families grow and heal from the impact of parental addiction.
Call us at 1-855-337-MACS to request a copy of the Parental Addiction book for your office. Supplies are limited, so call soon!
SUD and Parental Addiction Webinars for Providers
Sesame Street in Communities has developed a webinar series focused on substance use disorder and parental addiction to help providers support children and families.
Supporting Families in Child Welfare Affected by Substance Use Disorders Webinars for Providers (NCSACW)
Resources that providers and communities can use to better serve families in child welfare affected substance use disorders.
- maternal health inequities and the resulting disparities among patients with SUD
- Tools to reduce maternal mortality rates (especially among black patients / high mortality rates)
- addressing racism in SUD care for maternal health
- stigma around SUD and pregnat/postpartum patients
- Person-centered language
- Discrimination / lack of knowledge around LGTBQIA+ patients
Resources on meeting pregnant and postpartum patients where they are in the stages of change and aligning services accordingly.
An example for patients: https://harmreduction.org/issues/pregnancy-and-substance-use-a-harm-reduction-toolkit/
A free e-learning program for providers and students seeking knowledge and skills related to cultural competency, cultural humility, person-centered care, and combating implicit bias in maternal health care.
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV.
Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America
This guidance from an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates previous 2013 primary care guidelines.
AIDS Education & Training Center
Maryland education opportinities for providers from the Institute of Human Virology
HIV and Substance Use in the United States
Information and resources from the CDC.
The Connection Between Substance Use and HIV
Research report from NIDA.
Substance Use and HIV Risk
HIV Prevention: Reducing Risk from Alcohol & Drug Use from HIV.gov.
A section for information on possible barriers facing treatment for pregnant/postpartum individuals with substance use disorders.
PSI Hotline: 1-800-944-4773 (#1 for Español, #2 for English) OR Text en Español: 971-203-7773; Text in English: 800-944-4773
The Maryland Addiction Consultation Service is administered by the University of Maryland School of Medicine and funded by the Maryland Department of Health, Behavioral Health Administration.